Annual Net Margin
-0.56%
+186.26%+99.70%
31 December 2023
Summary:
CytomX Therapeutics annual net profit margin is currently -0.56%, with the most recent change of +186.26% (+99.70%) on 31 December 2023. During the last 3 years, it has risen by +309.98% (+99.82%). CTMX annual net margin is now at all-time high.CTMX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
17.16%
+43.18%+165.95%
30 September 2024
Summary:
CytomX Therapeutics quarterly net profit margin is currently 17.16%, with the most recent change of +43.18% (+165.95%) on 30 September 2024. Over the past year, it has increased by +14.01% (+444.76%). CTMX quarterly net margin is now -48.41% below its all-time high of 33.26%, reached on 31 March 2024.CTMX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTMX Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +444.8% |
| 3 y3 years | +99.8% | - |
| 5 y5 years | +99.9% | - |
CTMX Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +99.8% | -48.4% | +104.8% |
| 5 y | 5 years | at high | +99.9% | -48.4% | +104.8% |
| alltime | all time | at high | +100.0% | -48.4% | +102.4% |
CytomX Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 17.16%(-165.9%) |
| June 2024 | - | -26.02%(-178.2%) |
| Mar 2024 | - | 33.26%(+955.9%) |
| Dec 2023 | -0.56%(-99.7%) | 3.15%(-72.2%) |
| Sept 2023 | - | 11.34%(-357.7%) |
| June 2023 | - | -4.40%(-68.8%) |
| Mar 2023 | - | -14.09%(-67.7%) |
| Dec 2022 | -186.82%(-39.8%) | -43.61%(-83.3%) |
| Sept 2022 | - | -260.73%(+13.6%) |
| June 2022 | - | -229.49%(-35.1%) |
| Mar 2022 | - | -353.77%(+175.5%) |
| Dec 2021 | -310.54%(+227.8%) | - |
| Sept 2021 | - | -128.41%(+8.7%) |
| June 2021 | - | -118.14%(+21.3%) |
| Mar 2021 | - | -97.39%(+17.8%) |
| Dec 2020 | -94.73%(-80.8%) | - |
| Sept 2020 | - | -82.70%(-12.4%) |
| June 2020 | - | -94.41%(-483.6%) |
| Mar 2020 | - | 24.61%(-111.1%) |
| Dec 2019 | -493.74% | - |
| Sept 2019 | - | -221.24%(-31.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | -321.31%(+570.8%) |
| Mar 2019 | - | -47.90%(-83.0%) |
| Dec 2018 | -142.19%(+136.3%) | -281.00%(+50.0%) |
| Sept 2018 | - | -187.31%(+197.2%) |
| June 2018 | - | -63.02%(-42.3%) |
| Mar 2018 | - | -109.23%(-4869.9%) |
| Dec 2017 | -60.17%(-84.6%) | 2.29%(-105.4%) |
| Sept 2017 | - | -42.44%(-85.3%) |
| June 2017 | - | -288.12%(+306.6%) |
| Mar 2017 | - | -70.86%(-68.3%) |
| Dec 2016 | -391.54%(-14.6%) | -223.74%(-47.3%) |
| Sept 2016 | - | -424.49%(-7.4%) |
| June 2016 | - | -458.18%(-36.5%) |
| Mar 2016 | - | -721.05%(+24.8%) |
| Dec 2015 | -458.69%(-23.2%) | -577.82%(-5.6%) |
| Sept 2015 | - | -612.17%(+115.4%) |
| June 2015 | - | -284.19%(-20.3%) |
| Mar 2015 | - | -356.54%(+38.6%) |
| Dec 2014 | -597.01%(-65.0%) | -257.23%(+37.2%) |
| Sept 2014 | - | -187.42% |
| Dec 2013 | -1705.29% | - |
FAQ
- What is CytomX Therapeutics annual net profit margin?
- What is the all time high annual net margin for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly net margin year-on-year change?
What is CytomX Therapeutics annual net profit margin?
The current annual net margin of CTMX is -0.56%
What is the all time high annual net margin for CytomX Therapeutics?
CytomX Therapeutics all-time high annual net profit margin is -0.56%
What is CytomX Therapeutics quarterly net profit margin?
The current quarterly net margin of CTMX is 17.16%
What is the all time high quarterly net margin for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly net profit margin is 33.26%
What is CytomX Therapeutics quarterly net margin year-on-year change?
Over the past year, CTMX quarterly net profit margin has changed by +14.01% (+444.76%)